Dr Dee Tomic is a medically trained epidemiologist whose research is shaping national and international policy across occupational health, chronic conditions, and workplace equity. She is a Research Fellow at the Monash Centre for Occupational and Environmental Health (MonCOEH) and coordinates the Masters unit MPH5309 Occupational Health and Safety.

Dee completed her medical training at Monash before working at the Boston Consulting Group on major state and federal COVID-19 response initiatives. She completed a PhD in diabetes epidemiology at the Baker Institute in 2023, producing globally influential work including a landmark review of emerging diabetes complications (Nature Reviews Endocrinology) and the first multinational life-expectancy and lifetime-risk study in type 2 diabetes (The Lancet Diabetes & Endocrinology). Her diabetes research informs clinical guidelines (including the American Diabetes Associations's Standards of Care), and led to her appointment to the International Diabetes Federation Atlas Committee.

At MonCOEH, Dee has become an emerging leader in occupational health. Her work contributed to Australia becoming the first country to ban artificial stone, and she has produced world-first evidence on autoimmune disease, asthma, and the economic burden of silicosis among stone benchtop workers. In 2025, she received the David Goddard Best Paper Award from the Australian and New Zealand Society of Occupational Medicine for her asthma research. She has advised state and federal governments, Safe Work Australia, the Australian Defence Force, and the World Health Organization.

Dee leads two research streams at MonCOEH (Diabetes and Work; LGBTQ+ Workers) and is Chief Investigator on >$1.75 million in competitive funding. This includes federal funding to co-develop Australia’s National Silicosis Guidelines, WorkSafe Victoria funding to examine occupational disease among migrant workers, and philanthropic support for the Pride at Work Study, for which she is Primary CI. She also served as the primary research advisor for the 2025 World Diabetes Day campaign, “Diabetes in the Workplace”, shaping global workplace health initiatives across the International Diabetes Federation's network of 160 countries.

She has authored over 30 peer-reviewed publications (20+ first author), accrued >1,800 citations, and contributed extensively to national policy, teaching, and community-engaged research. Her work bridges clinical medicine, epidemiology, lived-experience partnerships, and policy translation – advancing health, equity, and safe work in Australia and internationally.